| Green tea (14) |  |
| Tea (15) | |
#Researchers develop green tea-based'missiles'to kill cancer cells more effectively Green tea has long been known for its antioxidant, anticancer, antiaging and antimicrobial properties.
A group of researchers from the Institute of Bioengineering and Nanotechnology (IBN) of A*STAR has taken the health benefits of green tea to the next level by using one of its ingredients to develop a drug delivery system
A key ingredient in green tea, epigallocatechin gallate (EGCG), is an antioxidant which is known to have therapeutic applications in the treatment of many disorders including cancer.
The numerous health benefits of green tea have inspired us to utilize it in drug delivery systems.
This is the first time that green tea has been used as a material to encapsulate and deliver drugs to cancer cells.
Our green tea nanocarrier not only delivered protein drugs more effectively to the cancer cells, the combination of carrier and drug also dramatically reduced tumor growth compared with the drug alone.
The research team conducted animal studies to evaluate the performance of IBN's green tea-based protein delivery system.
The study revealed that IBN's green tea nanocomplex loaded with Herceptin reduced tumor growth much more effectively
We have developed a green tea-based carrier in which the carrier itself displayed anticancer effect and can boost cancer treatment when used together with the protein drug.
Unlike conventional therapy our green tea carrier can eradicate more cancer cells and accumulate significantly less drugs in vital organs where they could cause adverse side effects.
IBN has filed a patent on their green tea nanocarrier and is developing this technology for clinical applications.
The green tea-based micellar complexes are also being examined for the delivery of active ingredients in personal care and nutritional products s
He also states that the benefits of the pomegranate are better than those of fruits like the cranberry, grapefruit, grape or black and green tea,
< Back - Next >
Overtext Web Module V3.0 Alpha
Copyright Semantic-Knowledge, 1994-2011